India, July 29 -- Synlogic, Inc. (SYBX), a biotechnology company, on Wednesday entered into a definitive merger agreement with Caldera Therapeutics, Inc. in an all-stock transaction to combine their businesses.
The private placement is expected to close concurrently with the merger.
Under the agreement, both companies will become wholly owned subsidiaries of a newly formed holding company.
Following the closing, the combined company will operate as Caldera Therapeutics and intends to list on the Nasdaq Capital Market under the ticker symbol "CALD."
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
In connection with the merger, Caldera secured commitments for an upsized concurrent private placement ex...